Enter assignee name

Forward Citations = 0

Loading Chart...

11 inventors (with patents filed for the assignee):

Muthusamy Jayaraman (5 out of 64 patents)

Stephen Scully (4 out of 6 patents)

Alim Ladha (3 out of 7 patents)

4. Vladimir Presnyak (3 out of 40 patents)

5. Brian Goodman (2 out of 8 patents)

6. Devin Scott Quinlan (2 out of 2 patents)

7. Inna Shcherbakova (2 out of 2 patents)

8. Mario Rodriguez Mestre (2 out of 2 patents)

9. Giedrius Gasiunas (1 out of 3 patents)

10. Elisabeth Narayanan (1 out of 2 patents)

11. Ganapathy Subramanian Sankaran (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12264328 - Gene editing components, systems, and methods of use (2025-04-01),

2. 12215068 - Constrained lipids and methods of use thereof (2025-02-04),

3. 12054739 - Engineered retrons and methods of use (2024-08-06),

4. 11866728 - Engineered retrons and methods of use (2024-01-09),

5. 11773061 - Cyclic lipids and methods of use thereof (2023-10-03),

Renagade Therapeutics Management Inc. is a biopharmaceutical company focused on developing innovative therapeutics to address unmet medical needs. With a commitment to advancing patient care, the company leverages cutting-edge research and technology to discover and develop treatments for a variety of conditions. The team at Renagade Therapeutics is comprised of experienced professionals from the pharmaceutical and clinical research sectors, dedicated to bringing novel therapies from the lab to the clinic. With a patient-centered approach, the company aims to improve health outcomes through rigorous scientific inquiry and development, fostering collaborations to enhance its research capabilities and accelerate drug development processes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

5 Patents

#336 in Cambridge, MA

#2,814 in Massachusetts

#50,178 in US

Cambridge, MA, United States of America

Renagade Therapeutics Management Inc.